Ledger.Open graph →
SEC Form D · Amendment · filed February 10, 2025

Lapix Therapeutics Inc

Offering
$6.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Anas Fathallah · Cambridge, MAExec · DirectorHenry Mckinnell · Cambridge, MADirectorFrancisco Leon · Cambridge, MADirectorAnthony Gibney · Cambridge, MADirectorJason Norris · Cambridge, MAExec · DirectorAnas Fathallah · Cambridge, MAExec · DirectorJason Norris · Cambridge, MAExec · DirectorHenry Mckinnell · Cambridge, MADirectorFrancisco Leon · Cambridge, MADirectorAnthony Gibney · Cambridge, MADirectorChristopher Hentemann · New York, NYDirector400 Capital GP LLC · New York, NYExec · DirectorPeter Henn · Farmington Hills, MIDirectorChristian J. Rottenkolber · Farmington Hills, MIExec · DirectorMaree H. Tucker · BALTIMORE, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗